Chronic heart failure and hypoalbuminemia are risk factors of poorer mRNA SARS-CoV-2 vaccine response in maintenance Hemodialysis patients (the COVaccinDia study).

Background: Chronic kidney disease represents an immunocompromising condition and a cause of a lower vaccine efficacy, even in patients undergoing maintenance dialysis. Recent SARS-CoV-2 outbreaks have prompted clinicians to better understand the underlying mechanisms and establish more suitable vaccination schedules.

Methods: In a single-center, retrospective, observational study of patients undergoing maintenance dialysis in France, we studied the factors associated with the intensity of the humoral response to a SARS-CoV-2 vaccine in this population, including specific dialysis-related variables.

Ischemic Ocular Involvement in Eosinophilic Granulomatosis with Polyangiitis: A Case Report.

Purpose: To report an uncommon, ocular ischemic involvement in a patient diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA).

Methods: Case report.

Results: A 77-year-old male exhibited headaches, scotomas and decreased visual acuity.

Giant cell arteritis mimics with severe consequences: a long-term monocentric inception cohort.

Objectives: To describe patients who underwent a temporal artery biopsy (TAB) for suspected GCA but were given a different diagnosis. We focused on a subset of alternate diagnoses mimicking GCA with ominous consequences of a delayed diagnosis or undue glucocorticoid treatment.

Methods: This was a single-centre retrospective study.

Upper respiratory tract and orofacial manifestations of new-onset giant cell arteritis: results from a large, prospective inception cohort study.

Objectives: Giant cell arteritis (GCA) often features upper respiratory tract (URT) and orofacial manifestations, which signal the involvement of external carotid artery branches. In this study, we aimed to describe the frequency of various URT/orofacial symptoms at GCA onset, as well as the main characteristics of patients presenting these symptoms.

Methods: We included all patients who were newly diagnosed with GCA between 1976 and April 2022 at the Internal Medicine Department of a tertiary-care hospital.